JAN 31, 2016 2:42 PM PST

Putting a Stop to Group A Streptococcus

WRITTEN BY: Kerry Evans
Researchers at the University of Notre Dame identified the mechanism by which Streptococcus pyogenes, also known as Group A Streptococcus (GAS), destroys red blood cells.

GAS infects nearly 700 million people a year worldwide, and nearly half a million die from the infection. People are usually infected by skin-to-skin contact, with the the most common types of infection being strep throat, cellulitis, and impetigo.  More severe infections cause toxic shock syndrome and necrotizing fasciitis (flesh-eating disease!).
 
Group A Streptococcus infects nearly 700 million people annually.

Once you’re infected with GAS, the bacteria sometimes make it into the bloodstream where they can lyse red blood cells with a peptide called Streptolysin S (SLS).  This is great for the bacteria (who love snacking on red blood cells), but bad for you.  Lucky for you, however, we now understand how SLS lyses red blood cells, making it possible to treat this aspect of GAS infection.

According to study author Shaun Lee, “we demonstrate that the long-observed red blood cell hemolysis by SLS is not caused by general destruction of the red blood cell membrane, as has been previously thought, but rather that the action is due to the ability of the SLS toxin to directly target a specific outer membrane protein on the surface of the red blood cell, the major erythrocyte anion exchange protein Band 3”.

The researchers also managed to block hemolysis by inhibiting the function of Band 3.  “By blocking the action of SLS toxin during a GAS infection, the pathology at the site of the infection could be drastically reduced”, says Lee, “these findings have tremendous potential for developing novel therapeutics to treat severe diseases caused by Group A Streptococcus”.
 

Sources: Science Daily, Wikipedia

 
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAR 18, 2020
Microbiology
MAR 18, 2020
The Coronavirus SARS-CoV-2 is Stable for Hours on Surfaces
SARS-CoV-2 is a coronavirus that causes an illness called COVID-19. There are now well over 210,000 confirmed cases worl ...
MAR 24, 2020
Cell & Molecular Biology
MAR 24, 2020
Certain Drugs May Raise the Risk of a Severe COVID-19 Infection
ACEIs and ARBs may make coronavirus infections worse, which can help explain why older adults are faring so much worse.
MAY 01, 2020
Microbiology
MAY 01, 2020
Once Thought to Make COVID-19 Worse, ACE Inhibitors Now Tested as Therapeutic
Researchers were once concerned that blood pressure medications may increase the risk of infection, or make an infection ...
MAY 03, 2020
Genetics & Genomics
MAY 03, 2020
Conspiracy Theories Surrounding the Origins of SARS-CoV-2
The origin of SARS-CoV-2, the pandemic virus that causes COVID-19, has become politicized as leaders seek to place blame ...
MAY 03, 2020
Microbiology
MAY 03, 2020
Understanding How Lyme Disease Persists in the Body
Lyme disease is a confounding illness that can be difficult to diagnose, and can cause a wide range of serious health pr ...
MAY 13, 2020
Microbiology
MAY 13, 2020
Low Vitamin D Levels Linked to COVID-19 Mortality
The COVID-19 pandemic has swept through various countries with widely discrepant mortality rates.
Loading Comments...